Lundberg Sven Ante
Director at VOR
- Sold, on record
- None
- Dollars the filings state
- Form 4 sales
- 0
- None on record
- Form 144 notices
- 1
- Proposed sales
- Companies
- 1
- Filed as an executive or holder
Companies
- VORVor Biopharma Inc.Director
Sales by reason
No Form 4 sale on record for Lundberg Sven Ante.
Timeline
- Aug 4, 2025Notice
Filed a notice to sell 29,432 shares
$62k29,432 shares
1 of 1
Every transaction
| Traded | Filed | Stock | Role | What | Amount | Price | Value | Held after | Source |
|---|---|---|---|---|---|---|---|---|---|
| Jun 12, 2026 | Jun 16, 2026 | QTTB | Director | AwardedStock Option (Right to Buy) | 9,810 | 9,810 | SEC | ||
| Jan 15, 2026 | Jan 30, 2026 | QTTB | Director | AwardedStock Option (Right to Buy) | 20,363 | $2.75 | $56k | 20,363 | SEC |
| Dec 12, 2025 | Dec 12, 2025 | Merus N.V. | President, CEO & PEO | Tendered | 83,435 | $97.00 | $8.1M | 0 | SEC |
| Dec 12, 2025 | Dec 12, 2025 | Merus N.V. | President, CEO & PEO | Returned to the companyShare Option (right to buy) | 2M | 0 | SEC | ||
| Nov 25, 2025 | Nov 28, 2025 | Merus N.V. | President, CEO & PEO | Gift | 196,209 | 9,192 | SEC | ||
| Oct 23, 2025 | Oct 27, 2025 | QTTB | Director | AwardedStock Option (Right to Buy) | 53,521 | 53,521 | SEC | ||
| May 22, 2025 | May 23, 2025 | VOR | Director | AwardedStock Option (Right to Buy) | 30,000 | 30,000 | SEC | ||
| Apr 17, 2025 | Apr 21, 2025 | Merus N.V. | President, CEO & PEO | Exercised or settledShare Option (right to buy) | 30,297 | $13.40 | $406k | 312,620 | SEC |
| Apr 17, 2025 | Apr 21, 2025 | Merus N.V. | President, CEO & PEO | Exercised options | 30,297 | $13.40 | $406k | 30,297 | SEC |
| Feb 24, 2025 | Feb 26, 2025 | QTTB | Director | Returned to the companyStock Option (Right to Buy) | 48,354 | 0 | SEC | ||
| Feb 24, 2025 | Feb 26, 2025 | QTTB | Director | AwardedStock Option (Right to Buy) | 70,178 | 23,140 | SEC | ||
| Feb 19, 2025 | Feb 21, 2025 | Merus N.V. | President, CEO & PEO | Gift | 81,202 | 40,601 | SEC | ||
| Feb 13, 2025 | Feb 18, 2025 | Merus N.V. | President, CEO & PEO | Exercised or settledShare Option (right to buy) | 16,372 | 351,628 | SEC | ||
| Feb 13, 2025 | Feb 18, 2025 | Merus N.V. | President, CEO & PEO | Exercised options | 16,372 | $24.43 | $400k | 40,601 | SEC |
| Jan 29, 2025 | Jan 31, 2025 | Merus N.V. | President, CEO & PEO | AwardedShare Option (right to buy) | 300,000 | 300,000 | SEC | ||
| Sep 25, 2024 | Sep 27, 2024 | QTTB | Director | AwardedStock Option (Right to Buy) | 1,316 | 1,316 | SEC | ||
| May 23, 2024 | May 28, 2024 | VOR | Director | AwardedStock Option (Right to Buy) | 30,000 | 30,000 | SEC | ||
| May 7, 2024 | May 9, 2024 | Merus N.V. | President, CEO & PEO | AwardedShare Option (right to buy) | 360,000 | 360,000 | SEC | ||
| Mar 25, 2024 | Mar 27, 2024 | QTTB | Director | AwardedStock Option (Right to Buy) | 12,767 | 12,767 | SEC | ||
| May 26, 2023 | Jun 2, 2023 | VOR | Director | AwardedStock Option (right to buy) | 30,000 | 30,000 | SEC | ||
| Feb 2, 2023 | Feb 3, 2023 | Merus N.V. | President, CEO & PFO | AwardedShare Option (right to buy) | 380,000 | 380,000 | SEC | ||
| Nov 3, 2022 | Nov 3, 2022 | Merus N.V. | President, CEO & PFO | Bought | 14,706 | $14.38 | $211k | 40,576 | SEC |
| Aug 22, 2022 | Aug 23, 2022 | Merus N.V. | President, CEO & PFO | Bought | 5,826 | $22.92 | $134k | 25,870 | SEC |
| Aug 19, 2022 | Aug 22, 2022 | Merus N.V. | President, CEO & PFO | Bought | 704 | $22.99 | $16k | 20,044 | SEC |
| Jul 12, 2022 | Jul 13, 2022 | Merus N.V. | President, CEO & PFO | Bought | 4,340 | $22.97 | $100k | 19,340 | SEC |
| Jun 14, 2022 | Jun 16, 2022 | VOR | Director | AwardedStock Option (right to buy) | 16,911 | 16,911 | SEC | ||
| Jan 31, 2022 | Feb 2, 2022 | Merus N.V. | President, CEO & PFO | AwardedShare Option (right to buy) | 295,000 | 295,000 | SEC | ||
| Aug 2, 2021 | Aug 4, 2021 | Merus N.V. | President, CEO & PFO | Exercised or settledShare Option (right to buy) | 15,000 | $13.36 | $200k | 339,120 | SEC |
| Aug 2, 2021 | Aug 4, 2021 | Merus N.V. | President, CEO & PFO | Exercised options | 15,000 | $13.36 | $200k | 15,000 | SEC |
| Mar 25, 2021 | Mar 29, 2021 | Merus N.V. | President, CEO & PFO | Gift | 74,000 | 0 | SEC | ||
| Mar 1, 2021 | Mar 3, 2021 | Merus N.V. | President, CEO & PFO | Exercised or settledShare Option (right to buy) | 74,000 | 351,747 | SEC | ||
| Mar 1, 2021 | Mar 3, 2021 | Merus N.V. | President, CEO & PFO | Exercised options | 74,000 | $13.38 | $990k | 74,000 | SEC |
| Feb 16, 2021 | Feb 18, 2021 | Merus N.V. | President, CEO & PFO | AwardedShare Option (right to buy) | 368,000 | 368,000 | SEC | ||
| Feb 5, 2021 | Feb 9, 2021 | VOR | Director | AwardedStock Option (right to buy) | 16,900 | 16,900 | SEC | ||
| Jan 3, 2020 | Jan 6, 2020 | Merus N.V. | President, CEO & PFO | AwardedShare Option (right to buy) | 414,917 | 414,917 | SEC | ||
| Oct 24, 2016 | Feb 10, 2017 | CRSP | Chief Scientific Officer | Bought | 400 | $14.00 | $6k | 505,617 | SEC |
| Oct 24, 2016 | Feb 10, 2017 | CRSP | Chief Scientific Officer | ConvertedSeries B Preferred Shares | 55,217 | 0 | SEC | ||
| Oct 24, 2016 | Feb 10, 2017 | CRSP | Chief Scientific Officer | Converted | 55,217 | 505,217 | SEC |